IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,532,078 | -18.2% | 663,647 | -2.7% | 0.03% | -17.5% |
| Q2 2023 | $12,873,623 | +2102.3% | 682,227 | +348.2% | 0.04% | +1900.0% |
| Q1 2023 | $584,559 | -45.4% | 152,229 | -29.4% | 0.00% | -50.0% |
| Q4 2022 | $1,070,179 | +10.8% | 215,762 | +44.0% | 0.00% | 0.0% |
| Q4 2020 | $966,000 | +61.3% | 149,795 | -10.0% | 0.00% | +100.0% |
| Q3 2020 | $599,000 | -22.9% | 166,495 | -1.4% | 0.00% | -50.0% |
| Q2 2020 | $777,000 | +5.4% | 168,895 | -21.8% | 0.00% | -20.0% |
| Q1 2020 | $737,000 | -36.5% | 215,995 | -5.1% | 0.01% | +25.0% |
| Q4 2019 | $1,161,000 | +105.5% | 227,495 | -2.5% | 0.00% | +100.0% |
| Q3 2019 | $565,000 | -41.5% | 233,395 | -47.6% | 0.00% | -33.3% |
| Q2 2019 | $966,000 | -20.2% | 445,055 | -0.4% | 0.00% | -40.0% |
| Q1 2019 | $1,211,000 | -44.0% | 446,955 | -0.8% | 0.01% | -50.0% |
| Q4 2018 | $2,163,000 | -36.4% | 450,555 | +25.4% | 0.01% | -16.7% |
| Q3 2018 | $3,402,000 | +1432.4% | 359,200 | +1474.9% | 0.01% | +1100.0% |
| Q2 2018 | $222,000 | – | 22,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |